CT

Celmatix Therapeutics

Biotechnology · New York, New York, United States · Founded 2009

About

They have a first-in-class oral fsh receptor agonist, a novel jnk inhibitor for endometriosis, and early-stage amh-targeting antibodies.

Company details may include data from People Data Labs, licensed CC BY 4.0.